Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

ClinicalTrials.gov ID: NCT04437368

Public ClinicalTrials.gov record NCT04437368. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

EXPLORE: A Phase II, Outcomes Assessor-masked, Multicentre, Randomised Study to Evaluate the Safety and Efficacy of Two Doses of GT005 Administered as a Single Subretinal Injection in Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical study was to evaluate the safety and efficacy of two doses of GT005 administered as a single subretinal injection in subjects with geographic atrophy secondary to age-related macular degeneration (AMD).

Study identification

NCT ID
NCT04437368
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gyroscope Therapeutics Limited
Industry
Enrollment
98 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 26, 2019 (Actual)
Primary completion
Apr 5, 2024 (Actual)
Completion
Apr 5, 2024 (Actual)
Last update posted
Jan 27, 2026

2019 – 2024

United States locations

U.S. sites
32
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Retinal Research Institute (retina consultants of AZ) Phoenix Arizona 85053 —
Retina Associates of Southern California Huntington Beach California 92647 —
Byers Eye Institute at Stanford Palo Alto California 94303 —
Retina Consultants San Diego Poway California 92064 —
VitreoRetinal Associates, P.A. Gainesville Florida 32607 —
Bascom Palmer Eye Institute Miami Florida 33136 —
Retina Vitreous Associates of Florida St. Petersburg Florida 33711 —
Southeast Retina Center Augusta Georgia 30909 —
University Retina Macula Associates PC Lemont Illinois 60439 —
Midwest Eye Institute Northside Indianapolis Indiana 46290 —
Wolfe Eye Clinic West Des Moines Iowa 50266 —
The Retina Care Center Baltimore Maryland 21209 —
Ophthalmic Consultants of Boston (OCB) Boston Massachusetts 02114 —
VitreoRetinal Surgery, PLLC Minneapolis Minnesota 55435 —
Sierra Eye Associates Reno Nevada 89502 —
Vision Research Center Eye Associates of New Mexico Albuquerque New Mexico 87109 —
Columbia University Medical Center New York New York 10032 —
Retina Associates of Western New York Rochester New York 14620 —
Cincinnati Eye Institute Cincinnati Ohio 45242 —
Cleveland Clinic Cleveland Ohio 44195 —
Oregon Retina Eugene Oregon 97401 —
Casey Eye Institute Portland Oregon 97239 —
Erie Retinal Surgery, INC Erie Pennsylvania 16507 —
Mid Atlantic Retina Philadelphia Pennsylvania 19107 —
Southeastern Retina Associates, PC Knoxville Tennessee 37922 —
Charles Retina Institute Memphis Tennessee 38138 —
Austin Research Center for Retina, PLLC Austin Texas 78705 —
Retina Consultants of Houston-TMC Bellaire Texas 77401 —
Texas Retina Associates Dallas Texas 75231 —
Retinal Consultants of San Antonio San Antonio Texas 78240 —
Department of Ophthalmology UW Medicine Seattle Washington 98104-2499 —
West Virginia University Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04437368, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04437368 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →